CVRx (CVRX) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CVRX CVRx Inc CVRX
56 GF Score
Price $5.16
GF Value $11.29
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is CVRx Net Loan?

Net Loan only applies to banks and insurance companies.

CVRX
56GF Score
CVRx Inc CVRX
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CVRx (CVRX) Overvalued in 2026?

Based on GuruFocus' analysis, CVRx stock appears to be undervalued. The current stock price of $5.16 is trading 54.3% below its estimated GF Value™ of $11.29. GuruFocus considers CVRx to be Possible Value Trap.

Key valuation signals for CVRX:

  • Net Loan:
  • GF Value™: $11.29 vs. price of $5.16 (54.3% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CVRx Business Description

Address 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
56GF Score

Get the complete analysis for CVRX

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.16
Price
$11.29
GF Value